Navigation Links
Proposed Bill to Protect Patient Access to Osteoporosis Testing by Reversing Cuts in Medicare Reimbursement
Date:11/26/2007

Study finds reimbursement for DXA test will save Medicare $1.14 billion over five years

WASHINGTON, Nov. 26 /PRNewswire-USNewswire/ -- In an effort to protect patient access to osteoporosis testing and reduce the physical and economic burden of osteoporosis for millions of Americans, Congress introduced H.R. 4206 "Medicare Fracture Prevention and Osteoporosis Testing Act of 2007," sponsored by Congresswoman Shelley Berkley (D-1st-NV) and supported by 41 original cosponsors. The bill calls for the reversal of drastic cuts in Medicare reimbursement for Dual Energy X-ray Absorptiometry, DXA, the imaging procedure accepted as the gold standard for diagnosing osteoporosis. This legislation builds on federal initiatives already in place to increase fracture prevention efforts and improve the prevention, detection and treatment of osteoporosis.

Medicare reimbursement for DXA has been cut to levels substantially below the cost to perform the procedure. As a result, many physicians, clinics and mobile services around the country are discontinuing this critical health service -- greatly reducing the public's access to the test and jeopardizing patients' quality of care.

This creates unnecessary barriers for those who cannot take the time for multiple healthcare provider visits and poses a serious threat to the frail and elderly who cannot travel long distances, particularly those living in rural areas. According to estimates, less than 14 percent of those who are eligible are being tested for osteoporosis; by passing this bill we can prevent this number from plunging even lower.

"In the U.S. today, one in two women and one in four men 50 and over will break a bone due to osteoporosis. We need Congress to pass this legislation in order to assure that access to testing is preserved and that those at risk of devastating and costly fractures are diagnosed and properly treated to prevent fractures," said Ethel Siris, M.D., president of the National Osteoporosis Foundation.

A recent study completed by The Lewin Group finds that restoring DXA reimbursement to the 2006 levels will save the Medicare program $1.14 billion over five years due to the reduced number of osteoporotic fractures. DXA is a key tool in identifying those at risk for osteoporosis and helping those with the disease monitor their bone health. It is a recognized, reliable tool for preventing and reducing costly fractures, which account for $18 million in national costs of direct care and are projected to increase by 50 percent over the next two decades, reaching $25.3 billion in 2025.

Osteoporosis now causes an estimated 2 million fractures each year and often results in immobility, pain, placement in a nursing home, isolation and other health problems -- conditions and circumstances that could largely be prevented through proper bone density testing and diagnosis.

The National Osteoporosis Foundation applauds Representative Berkley and all of the cosponsors for introducing H.R. 4206 "Medicare Fracture Prevention and Osteoporosis Testing Act of 2007" and we ask Congress to pass this bill and support access to care for the 10 million individuals with osteoporosis and the 34 million individuals estimated to have low bone mass across the country.

Established in 1984, the National Osteoporosis Foundation is the nation's leading voluntary health organization solely dedicated to osteoporosis and bone health. Its mission is to prevent osteoporosis and related fractures, to promote lifelong bone health, to help improve the lives of those affected by osteoporosis, and to find a cure through programs of awareness, advocacy, public and health professional education and research. For more information on osteoporosis and bone health, contact NOF online at http://www.nof.org or by telephone (800) 231-4222.


'/>"/>
SOURCE National Osteoporosis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
4. Paramount Acquisition Corp. Announces Record Date of October 1, 2007 for Proposed Acquisition of Chem Rx
5. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
6. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
7. Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab
8. Screening Proposed for Childhood Cholesterol Levels
9. Pelosi Statement on Proposed Entitlement Task Force
10. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
11. AARP Calls on State Regulators to Reject Proposed Settlement of TXU Buyout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: